The week’s best buys

Joules Group The Times

The colourful clothes and homewares retailer, which floated last year, has a large potential reach beyond the UK. Sales are up 20%, and profits by 34%, but it is still an “immature” business. One for the adventurous. Buy. 280p.

Indivior The Times

The drugs firm, spun out of Reckitt Benckiser, has built up a dominant position in the US, where it is well-placed to profit from the opioid addiction crisis. A monthly injectable drug, RBP-6000, is close to approval. Buy. 404.25p.

Lok’nstore Group Investors Chronicle

Occupancy rates at the self-storage outfit are up 6.5%, and a pipeline of seven new stores will increase space by 26%. Managing stores for third-party owners generates additional revenue. Trades at a discount to rivals. Buy. 377.5p.

Playtech The Mail on Sunday

Shares in the gaming and sports betting software firm have fallen 22% after weak Q3 trading. Investec has reduced its price target from £11.20 to £10.30, but nonetheless believes shares have been oversold. Buy. 770p.

Prudential The Daily Telegraph

The £48bn insurance giant has undergone a “seismic transformation”, moving its focus away from UK annuities to the rapidly growing Asian savings and insurance market. Undervalued and well-placed to thrive in Asia. Buy. £18.52.

Tate & Lyle The Times

Uncertainty around US trade agreements has hit the ingredients firm. Yet it is performing well, with rising speciality and bulk ingredient sales. Yields 4.3%, and favourable Nafta talks would boost shares. Buy. 675.5p.